Objectives: In this study, the pharmacological properties of six spirocyclic piperidines 1-6 showing very high σ receptor affinity (K  = 0.2-16 nm) were investigated.

Methods: In vitro receptor binding studies, retinal ganglion assay and in vivo capsaicin assay were used to determine the affinity, selectivity and activity. Influence on human tumour cell growth (cell lines A427, LCLC-103H, 5637 and DAN-G) was determined in different assays. The effect on the ergosterol and cholesterol biosynthesis was determined by GLC/MS analysis.

Key Findings: Receptor binding studies demonstrated high selectivity for the σ receptor. The increased Ca influx mediated by 2 and the analgesic activity of 1, 4, 5 and 6 confirm σ receptor antagonistic activity. Inhibition of human tumour cell growth further supports the σ antagonistic effects. Treatment of A427 tumour cells with 2 led to cell detachment and cell degradation. Whereas the ergosterol biosynthesis was not affected, the sterol C14-reductase, a key enzyme in the cholesterol biosynthesis, was weakly inhibited.

Conclusions: Due to the high selectivity, off-target effects are not expected. The antiallodynic activity underlines the clinical potential of the spirocyclic piperidines for the treatment of neuropathic pain. Due to the antiproliferative activity, the spirocyclic σ antagonists represent promising antitumour agents.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jphp.13196DOI Listing

Publication Analysis

Top Keywords

spirocyclic piperidines
8
receptor binding
8
binding studies
8
human tumour
8
tumour cell
8
cell growth
8
cholesterol biosynthesis
8
high selectivity
8
receptor
6
activity
5

Similar Publications

Synthesis and structure-affinity relationships of spirocyclic σ receptor ligands with tetrahydropyran scaffold.

Eur J Med Chem

January 2025

Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Corrensstraße 48, D-48149, Münster, Germany. Electronic address:

The σ receptor plays a key role in the regulation of various processes in the human body; it is involved in the development of neurodegenerative and neuropsychiatric diseases and is overexpressed in several human tumors rendering it an important target for potential drug candidates. In this project, spirocyclic σ receptor ligands with different substituents in 4- and 9-position were synthesized and investigated for their σ receptor affinity and selectivity over related targets. The σ affinity of the ligands was correlated with their lipophilicity (logD value) giving insight into their lipophilic ligand efficiency (LLE).

View Article and Find Full Text PDF

Spiro N-heterocycles, particularly aza-spiro piperidines, have shown significant promise in pharmaceutical applications due to their ability to enhance physicochemical properties. Despite their potential, the preparation of these complex structures poses significant challenges. To address this, we propose a one-pot dearomative spirocyclization reaction of ynamides.

View Article and Find Full Text PDF

The presence of a small spirocyclic ring at an adjacent position alters the conformational preference for equatorial substitution in six-membered rings. DFT calculations and low-temperature H NMR experiments demonstrate that alkyl groups larger than methyl possess negative A-values when geminal to a spirocyclopropane, with larger groups such as isopropyl and -butyl being exclusively axial at -78 °C. Similar effects are found for heteroatoms, including halogens, and for a range of other electron-withdrawing substituents.

View Article and Find Full Text PDF

This review describes novel organocatalytic methods for the enantioselective construction of spiroindans and spirochromans and the application of the methods to the total synthesis of natural products. We developed an intramolecular Friedel-Craftstype 1,4-addition in which the substrates were a resorcinol derivative and 2-cyclohexenone linked by an alkyl chain. The reaction proceeded smoothly in the presence of a cinchonidine-based primary amine (30 mol%) with water and p-bromophenol as additives.

View Article and Find Full Text PDF

Unlabelled: Chronic lymphocytic leukemia (CLL) cell survival and growth is fueled by the induction of B-cell receptor (BCR) signaling within the tumor microenvironment (TME) driving activation of NFκB signaling and the unfolded protein response (UPR). Malignant cells have higher basal levels of UPR posing a unique therapeutic window to combat CLL cell growth using pharmacologic agents that induce accumulation of misfolded proteins. Frontline CLL therapeutics that directly target BCR signaling such as Bruton tyrosine kinase (BTK) inhibitors (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!